One-carbon metabolism: linking nutritional biochemistry to epigenetic programming of long-term development

CE Clare, AH Brassington, WY Kwong… - Annual review of …, 2019 - annualreviews.org
One-carbon (1C) metabolism comprises a series of interlinking metabolic pathways that
include the methionine and folate cycles that are central to cellular function, providing 1C …

[HTML][HTML] Factor v Leiden thrombophilia

JL Kujovich - Genetics in medicine, 2011 - Elsevier
Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to
activated Protein C and an increased risk for venous thromboembolism. Deep venous …

VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence …

SM Bates, IA Greer, S Middeldorp, DL Veenstra… - Chest, 2012 - Elsevier
Background The use of anticoagulant therapy during pregnancy is challenging because of
the potential for both fetal and maternal complications. This guideline focuses on the …

Thrombophilia in pregnancy: a systematic review

L Robertson, O Wu, P Langhorne… - British journal of …, 2006 - Wiley Online Library
Growing evidence suggests that thrombophilia is associated with venous thromboembolism
(VTE) and adverse pregnancy outcomes. However, methodological limitations have made it …

Thrombophilic disorders and fetal loss: a meta-analysis

E Rey, SR Kahn, M David, I Shrier - The Lancet, 2003 - thelancet.com
Background Our aim was to assess the strength of the controversial association between
thrombophilia and fetal loss, and to examine whether it varies according to the timing or …

Recurrent miscarriage

DW Branch, C Heuser - … and Infertility: Integrating Modern Clinical and …, 2010 - Springer
Recurrent miscarriage is a common pathology fond in 1% to 5% of reproductively active
couples. This chapter discusses the possible causes of recurrent miscarriage, and …

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines

SM Bates, IA Greer, I Pabinger, S Sofaer, J Hirsh - Chest, 2008 - Elsevier
This article discusses the management of venous thromboembolism (VTE) and
thrombophilia, as well as the use of antithrombotic agents, during pregnancy and is part of …

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

SM Bates, IA Greer, J Hirsh, JS Ginsberg - Chest, 2004 - Elsevier
This chapter about the use of antithrombotic agents during pregnancy is part of the Seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …

How strong is the association between maternal thrombophilia and adverse pregnancy outcome?: A systematic review

Z Alfirevic, D Roberts, V Martlew - … Journal of Obstetrics & Gynecology and …, 2002 - Elsevier
Objective: To determine whether inherited and acquired thrombophilias are associated with
adverse obstetric complications. Study Design: A systematic review; studies where women …

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

JC Gris, E Mercier, I Quéré, G Lavigne-Lissalde… - Blood, 2004 - ashpublications.org
The prospective evaluation of the effect of thromboprophylaxis in women with one
unexplained pregnancy loss from the 10th week of amenorrhea was performed. A total of …